Cartesian Therapeutics Files 8-K
Ticker: RNAC · Form: 8-K · Filed: Mar 3, 2025 · CIK: 1453687
| Field | Detail |
|---|---|
| Company | Cartesian Therapeutics, Inc. (RNAC) |
| Form Type | 8-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
Cartesian Therapeutics filed an 8-K on 3/3/25, check it for Reg FD and financials.
AI Summary
Cartesian Therapeutics, Inc. filed an 8-K on March 3, 2025, reporting information under Regulation FD and including financial statements and exhibits. The company, previously known as Selecta Biosciences Inc. until January 9, 2009, is incorporated in Delaware and headquartered in Frederick, MD.
Why It Matters
This filing provides an update on Cartesian Therapeutics' regulatory disclosures and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain any new material events or risks.
Key Players & Entities
- Cartesian Therapeutics, Inc. (company) — Registrant
- Selecta Biosciences Inc. (company) — Former company name
- March 3, 2025 (date) — Date of report
- Frederick, MD (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report information under Regulation FD and to include financial statements and exhibits.
When was Cartesian Therapeutics, Inc. incorporated?
Cartesian Therapeutics, Inc. was incorporated in Delaware.
What is the address of Cartesian Therapeutics, Inc.'s principal executive offices?
The address of Cartesian Therapeutics, Inc.'s principal executive offices is 7495 New Horizon Way, Frederick, MD 21703.
What was Cartesian Therapeutics, Inc.'s former company name?
Cartesian Therapeutics, Inc.'s former company name was Selecta Biosciences Inc.
On what date was the name change from Selecta Biosciences Inc. to Cartesian Therapeutics, Inc. effective?
The date of the name change from Selecta Biosciences Inc. was January 9, 2009.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 3, 2025 regarding Cartesian Therapeutics, Inc. (RNAC).